Form EFFECT Cocrystal Pharma, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 1, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stellus Private Credit BDC Announces $0.31 Third Quarter 2026 Regular Dividend, Payable Monthly in Increments of $0.1033 in July, August, and September 2026
- SL Green Continues SUMMIT Global Expansion in Tokyo
- The RealReal Announces Timing of Its Second Quarter 2026 Earnings Conference Call
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
